{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:45:32Z","timestamp":1780591532414,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ejphar.2012.06.030","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T06:10:50Z","timestamp":1341555050000},"page":"1-3","source":"Crossref","is-referenced-by-count":34,"title":["Targeting c-kit in the therapy of mast cell disorders: Current update"],"prefix":"10.1016","volume":"690","author":[{"given":"Dina S.","family":"El-Agamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.06.030_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2011.09.007","article-title":"The role of mast cells in allergic inflammation","volume":"106","author":"Amin","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejphar.2012.06.030_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/labinvest.3700419","article-title":"Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma","volume":"86","author":"Berlin","year":"2006","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2012.06.030_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1164\/rccm.200403-385OC","article-title":"Treatment of cockroach allergen asthma model with imatinib attenuates airway responses","volume":"171","author":"Berlin","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2012.06.030_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2007.07.010","article-title":"The allergic cascade: review of the most important molecules in the asthmatic lung","volume":"113","author":"Bloemen","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ejphar.2012.06.030_bib5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1160\/TH11-05-0291","article-title":"Mast cells in atherosclerosis","volume":"106","author":"Bot","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2012.06.030_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2222.2007.02886.x","article-title":"The mast cell and allergic diseases: role in pathogenesis and implications for therapy","volume":"38","author":"Brown","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2012.06.030_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-065X.2007.00504.x","article-title":"Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy","volume":"217","author":"Eklund","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2012.06.030_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/07853890310001339","article-title":"Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases","volume":"35","author":"Eklund","year":"2003","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejphar.2012.06.030_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2012.01.039","article-title":"Anti-allergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions","volume":"680","author":"El-Agamy","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2012.06.030_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000236928","article-title":"Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor","volume":"107","author":"Galli","year":"1995","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri1782","article-title":"Integrated signaling pathways for mast-cell activation","volume":"6","author":"Gilfillan","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib13","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","article-title":"PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects","volume":"107","author":"Gleixner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2012.06.030_bib14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3324\/haematol.11339","article-title":"Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT","volume":"92","author":"Gleixner","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.ejphar.2012.06.030_bib15","doi-asserted-by":"crossref","first-page":"13283","DOI":"10.1073\/pnas.0702654104","article-title":"The Btk tyrosine kinase is a major target of the Bcr\u2013Abl inhibitor dasatinib","volume":"104","author":"Hantschel","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2012.06.030_bib16","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1681\/ASN.2008010015","article-title":"Role of mast cells in progressive renal diseases","volume":"19","author":"Holdsworth","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","article-title":"Mastocytosis: state of the art","volume":"74","author":"Horny","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.ejphar.2012.06.030_bib18","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.2174\/092986707782793998","article-title":"Regulation of mast cell development by inflammatory factors","volume":"14","author":"Hu","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2012.06.030_bib19","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2004-02-0631","article-title":"Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells","volume":"104","author":"Hundley","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2012.06.030_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.leukres.2010.02.024","article-title":"Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib","volume":"34","author":"Ikezoe","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejphar.2012.06.030_bib21","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/bjp.2008.204","article-title":"Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders","volume":"154","author":"Jensen","year":"2008","journal-title":"B. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.107.125237","article-title":"Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation","volume":"324","author":"Jensen","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.06.030_bib23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/ard.2004.029835","article-title":"Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis","volume":"64","author":"Juurikivi","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2012.06.030_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1600-0625.2009.00860.x","article-title":"Mast cells: novel clinical perspectives from recent insights","volume":"18","author":"Kneilling","year":"2009","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1073176","article-title":"Mast cells: a cellular link between autoantibodies and inflammatory arthritis","volume":"297","author":"Lee","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2012.06.030_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000317102","article-title":"Mast cell infiltration is involved in renal interstitial fibrosis in a rat model of protein-overload nephropathy","volume":"33","author":"Li","year":"2010","journal-title":"Kidney Blood Pressure Res."},{"key":"10.1016\/j.ejphar.2012.06.030_bib27","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1164\/rccm.201007-1157OC","article-title":"c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice","volume":"183","author":"Lindsey","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2012.06.030_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00011-005-1346-9","article-title":"The contribution of mast cells to the late-phase of allergic asthma in rats","volume":"54","author":"Liu","year":"2005","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2012.06.030_bib29","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.170.4.1625","article-title":"Cutting edge: distinct Toll like receptor 2 activators selectively induce different classes of mediator production from human mast cells","volume":"170","author":"McCurdy","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000236955","article-title":"The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis","volume":"107","author":"Mekori","year":"1995","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-065X.2007.00520.x","article-title":"Mast cells in the promotion and limitation of chronic inflammation","volume":"217","author":"Metz","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2012.06.030_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","article-title":"Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options","volume":"4","author":"Molderings","year":"2011","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:34:2:97","article-title":"Development, migration, and survival of mast cells","volume":"34","author":"Okayama","year":"2006","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ejphar.2012.06.030_bib34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/156800907781386614","article-title":"Kit: molecule of interest for the diagnosis and treatment of mastocytosis and other neoplastic disorders","volume":"7","author":"Patnaik","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejphar.2012.06.030_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5415\/apallergy.2011.1.1.36","article-title":"Irritable bowel syndrome - An inflammatory disease involving mast cells","volume":"1","author":"Philpott","year":"2011","journal-title":"Asia Pac. Allergy"},{"key":"10.1016\/j.ejphar.2012.06.030_bib36","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1158\/1078-0432.CCR-05-2275","article-title":"Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate","volume":"12","author":"Prenen","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2012.06.030_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1196\/annals.1443.023","article-title":"Mast cells: multifaceted immune cells with diverse roles in health and disease","volume":"1143","author":"Rao","year":"2008","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejphar.2012.06.030_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2009.05122.x","article-title":"Signaling of c-kit in dendritic cells influences adaptive immunity","volume":"1183","author":"Ray","year":"2010","journal-title":"Ann. NY. Acad. Sci."},{"key":"10.1016\/j.ejphar.2012.06.030_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejphar.2005.12.067","article-title":"Stem cell factor and its receptor c-Kit as targets for inflammatory diseases","volume":"533","author":"Reber","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000321261","article-title":"Effect of imatinib on airway smooth muscle thickening in a murine model of chronic asthma","volume":"155","author":"Rhee","year":"2011","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.191.5.813","article-title":"Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis","volume":"191","author":"Secor","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2012.06.030_bib42","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1189\/jlb.0602284","article-title":"STI571 inhibits growth and adhesion of human mast cells in culture","volume":"74","author":"Takeuchi","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1196\/annals.1366.025","article-title":"The critical role of mast cells in allergy and inflammation","volume":"1088","author":"Theoharides","year":"2006","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejphar.2012.06.030_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-065X.2007.00519.x","article-title":"Differential release of mast cell mediators and the pathogenesis of inflammation","volume":"217","author":"Theoharides","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2012.06.030_bib45","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.tips.2011.05.005","article-title":"Mast cells squeeze the heart and stretch the gird: their role in atherosclerosis and obesity","volume":"32","author":"Theoharides","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2012.06.030_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2008.09.010","article-title":"Tyrosine kinases as targets in rheumatoid arthritis","volume":"9","author":"Tristano","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2012.06.030_bib47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.leukres.2011.05.006","article-title":"Tyrosine kinase inhibitors in the treatment of systemic mastocytosis","volume":"35","author":"Ustun","year":"2011","journal-title":"Leuk Res."},{"key":"10.1016\/j.ejphar.2012.06.030_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190400010775","article-title":"Mastocytosis: pathology, genetics, and current options for therapy","volume":"46","author":"Valent","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejphar.2012.06.030_bib49","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.leukres.2006.04.005","article-title":"Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kit","volume":"30","author":"Verstovsek","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejphar.2012.06.030_bib50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1398-9995.2011.02717.x","article-title":"Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen-induced anaphylaxes in mice","volume":"67","author":"Yamaki","year":"2012","journal-title":"Allergy"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912005420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912005420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T12:27:18Z","timestamp":1714134438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912005420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":50,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0014299912005420"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.06.030","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}